Quarterly report pursuant to Section 13 or 15(d)

Nature of Operations

v3.8.0.1
Nature of Operations
9 Months Ended
Sep. 30, 2017
Nature of Operations  
Nature of Operations

1.Nature of Operations

 

We were incorporated in the state of Delaware on June 14, 1996. We are engaged in the discovery and development of novel small molecule drugs that significantly improve the lives of patients with immune and hematological disorders, cancer and rare diseases.